INTRODUCTION: End-stage renal disease (ESRD) affects more than 1500 people per million population in countries with a high prevalence, such as Japan, Taiwan, and the US. Approximately two-thirds of people with ESRD receive haemodialysis, one quarter have kidney transplants, and one tenth receive peritoneal dialysis. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of different doses for peritoneal dialysis? What are the effects of different doses and membrane fluxes for haemodialysis? What are the effects of interventions aimed at preventing secondary complications? We searched: Medline, Embase, The Cochrane Library, and other important databases up to October 2009 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 26 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: cinacalcet, darbepoetin, erythropoietin, haemodialysis (standard-dose, increased-dose), high membrane-flux haemodialysis, increased-dose peritoneal dialysis, low membrane-flux haemodialysis, mupirocin, sevelamer, standard-dose dialysis, and statins.
INTRODUCTION: End-stage renal disease (ESRD) affects more than 1500 people per million population in countries with a high prevalence, such as Japan, Taiwan, and the US. Approximately two-thirds of people with ESRD receive haemodialysis, one quarter have kidney transplants, and one tenth receive peritoneal dialysis. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of different doses for peritoneal dialysis? What are the effects of different doses and membrane fluxes for haemodialysis? What are the effects of interventions aimed at preventing secondary complications? We searched: Medline, Embase, The Cochrane Library, and other important databases up to October 2009 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). RESULTS: We found 26 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: cinacalcet, darbepoetin, erythropoietin, haemodialysis (standard-dose, increased-dose), high membrane-flux haemodialysis, increased-dose peritoneal dialysis, low membrane-flux haemodialysis, mupirocin, sevelamer, standard-dose dialysis, and statins.
Authors: Yves Vanrenterghem; Peter Bárány; Johannes F E Mann; Peter G Kerr; Janet Wilson; Nigel F Baker; Stephen J Gray Journal: Kidney Int Date: 2002-12 Impact factor: 10.612
Authors: Yoshio N Hall; Chi-yuan Hsu; Carlos Iribarren; Jeanne Darbinian; Charles E McCulloch; Alan S Go Journal: Kidney Int Date: 2005-11 Impact factor: 10.612
Authors: Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag Journal: JAMA Date: 2004-01-28 Impact factor: 56.272
Authors: David Wayne Johnson; Robert MacGinley; Troy David Kay; Carmel Mary Hawley; Scott Bryan Campbell; Nicole Maree Isbel; Peter Hollett Journal: Nephrol Dial Transplant Date: 2002-10 Impact factor: 5.992
Authors: Robin Huang; Na Liu; Mary Ann Nicdao; Mary Mikaheal; Tanya Baldacchino; Annabelle Albeos; Kathy Petoumenos; Kamal Sud; Jinman Kim Journal: J Am Med Inform Assoc Date: 2020-02-01 Impact factor: 4.497
Authors: Nur Raziana Binti Rozi; Wan Ahmad Syahril Rozli Wan Ali; Che Rosle Bin Draman; Hafizah Binti Pasi Journal: Indian J Palliat Care Date: 2021-02-17
Authors: Juliana Zambrano; Perla Romero; Regina Longley; Jeff C Huffman; Abraham Cohen-Bucay; Christopher M Celano Journal: J Acad Consult Liaison Psychiatry Date: 2022-03-10
Authors: Eba'a Hafi; Ro'ya Soradi; Sarah Diab; Ahmad M Samara; Marah Shakhshir; Malik Alqub; Sa'ed H Zyoud Journal: J Health Popul Nutr Date: 2021-07-05 Impact factor: 2.000
Authors: Frank De Stefano; Luis H Paz Rios; Brian Fiani; Jawed Fareed; Alfonso Tafur Journal: Clin Appl Thromb Hemost Date: 2021 Jan-Dec Impact factor: 2.389